File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: What is the appropriate timing for surgery after neoadjuvant chemoradiation for esophageal cancer
Title | What is the appropriate timing for surgery after neoadjuvant chemoradiation for esophageal cancer |
---|---|
Authors | |
Keywords | Medical sciences Surgery |
Issue Date | 2011 |
Publisher | Springer New York LLC. The Journal's web site is located at http://link.springer.de/link/service/journals/00268/ |
Citation | The 2011 International Surgical Week (ISW 2011), Yokohama, Japan, 28 August-1 September 2011. In World Journal of Surgery, 2011, v. 35 suppl. 1, p. S172, abstract no. 0450 How to Cite? |
Abstract | INTRODUCTION: The optimal interval between neoadjuvant chemoradiation (CRT) and surgery has not been elucidated for squamous esophageal cancer (ESC). The aim of this study is to evaluate the impact of this time interval on postoperative and long-term outcomes. MATERIAL AND METHODS: A total of 107 patients with intrathoracic ESC treated with neoadjuvant CRT between 2002 and 2009 were analyzed from a prospectively collected database. Patients were divided into three groups based on the interval between completion of CRT and surgery: group A: <40 days (n = 16); B: 41–80 days (n = 60); and C: >80 days (n = 31). Survival was also compared by dividing these patients into two groups using the median interval (64 days) as the cutoff point: group A* (n = 54) and B* (n = 53). Intraoperative parameters, postoperative outcomes, pathological data and long-term survival were investigated. RESULTS: The three groups were comparable in patient and tumor characteristics, intraoperative parameters, postoperative morbidity and mortality. Pathological analysis showed that the median number of lymph nodes harvested was comparable. All three groups had significant rate of downstaging [A: n = 8 (50%), B: n = 43 (71.7%), C: n = 21 (67.7%)]. For group A, the rate of R0 resection was significantly lower than the other two groups [A: n = 9 (56.3%), B: n = 54 (90%), C: n = 23 (74.2%), P = 0.006]. The pathological complete response (pCR) rates were comparable [A: n = 5(31.2%), B: n = 21(35%), C: n = 6(19.4%), P = 0.301]. Overall 3-year survival were 73.4, 66.7, and 53.5% respectively, P = 0.23. After R0 resection, group A had longer 3-year survival (100%) compared to group B (73%) and C (64.4%), (log-rank test: A vs. B, P = 0.04; A vs. C, P = 0.015; B vs. C, P = 0.315). Using the median interval (64 days) as the dividing point, the overall 3-year survivals of group A* and B* were 71.1 and 56.5%, respectively, P = 0.081. If R0 was achieved, the 3-year survival of group A* and B* were 83.4 and 64.3%, P = 0.023. With R0 resection, though statistically not significant, there was no tumor recurrence detected in group A, whereas 8 (14.8%) and 5 (21.7%) patients had tumor recurrence in group B and C during follow up, P = 0.302. CONCLUSION: Interval between CRT and surgery did not affect postoperative morbidity and mortality. Although early surgery seemed to result in less R0 resection, overall survival was not compromised. In those with R0 resection, better survival was attained. Delayed surgery may compromise long-term survival. |
Description | Conference Theme: Exploring the Future of Surgery Session 22.01 - ISDS Free Papers, Esophagus 1: Malignant This journal suppl. is proceedings of ISW 2011 |
Persistent Identifier | http://hdl.handle.net/10722/140589 |
ISSN | 2023 Impact Factor: 2.3 2023 SCImago Journal Rankings: 0.772 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tong, D | en_US |
dc.contributor.author | Law, S | en_US |
dc.contributor.author | Kwong, DLW | en_US |
dc.contributor.author | Chan, SY | en_US |
dc.contributor.author | Wong, KH | en_US |
dc.date.accessioned | 2011-09-23T06:15:28Z | - |
dc.date.available | 2011-09-23T06:15:28Z | - |
dc.date.issued | 2011 | en_US |
dc.identifier.citation | The 2011 International Surgical Week (ISW 2011), Yokohama, Japan, 28 August-1 September 2011. In World Journal of Surgery, 2011, v. 35 suppl. 1, p. S172, abstract no. 0450 | en_US |
dc.identifier.issn | 0364-2313 | - |
dc.identifier.uri | http://hdl.handle.net/10722/140589 | - |
dc.description | Conference Theme: Exploring the Future of Surgery | - |
dc.description | Session 22.01 - ISDS Free Papers, Esophagus 1: Malignant | - |
dc.description | This journal suppl. is proceedings of ISW 2011 | - |
dc.description.abstract | INTRODUCTION: The optimal interval between neoadjuvant chemoradiation (CRT) and surgery has not been elucidated for squamous esophageal cancer (ESC). The aim of this study is to evaluate the impact of this time interval on postoperative and long-term outcomes. MATERIAL AND METHODS: A total of 107 patients with intrathoracic ESC treated with neoadjuvant CRT between 2002 and 2009 were analyzed from a prospectively collected database. Patients were divided into three groups based on the interval between completion of CRT and surgery: group A: <40 days (n = 16); B: 41–80 days (n = 60); and C: >80 days (n = 31). Survival was also compared by dividing these patients into two groups using the median interval (64 days) as the cutoff point: group A* (n = 54) and B* (n = 53). Intraoperative parameters, postoperative outcomes, pathological data and long-term survival were investigated. RESULTS: The three groups were comparable in patient and tumor characteristics, intraoperative parameters, postoperative morbidity and mortality. Pathological analysis showed that the median number of lymph nodes harvested was comparable. All three groups had significant rate of downstaging [A: n = 8 (50%), B: n = 43 (71.7%), C: n = 21 (67.7%)]. For group A, the rate of R0 resection was significantly lower than the other two groups [A: n = 9 (56.3%), B: n = 54 (90%), C: n = 23 (74.2%), P = 0.006]. The pathological complete response (pCR) rates were comparable [A: n = 5(31.2%), B: n = 21(35%), C: n = 6(19.4%), P = 0.301]. Overall 3-year survival were 73.4, 66.7, and 53.5% respectively, P = 0.23. After R0 resection, group A had longer 3-year survival (100%) compared to group B (73%) and C (64.4%), (log-rank test: A vs. B, P = 0.04; A vs. C, P = 0.015; B vs. C, P = 0.315). Using the median interval (64 days) as the dividing point, the overall 3-year survivals of group A* and B* were 71.1 and 56.5%, respectively, P = 0.081. If R0 was achieved, the 3-year survival of group A* and B* were 83.4 and 64.3%, P = 0.023. With R0 resection, though statistically not significant, there was no tumor recurrence detected in group A, whereas 8 (14.8%) and 5 (21.7%) patients had tumor recurrence in group B and C during follow up, P = 0.302. CONCLUSION: Interval between CRT and surgery did not affect postoperative morbidity and mortality. Although early surgery seemed to result in less R0 resection, overall survival was not compromised. In those with R0 resection, better survival was attained. Delayed surgery may compromise long-term survival. | - |
dc.language | eng | en_US |
dc.publisher | Springer New York LLC. The Journal's web site is located at http://link.springer.de/link/service/journals/00268/ | - |
dc.relation.ispartof | World Journal of Surgery | en_US |
dc.rights | The original publication is available at www.springerlink.com | - |
dc.subject | Medical sciences | - |
dc.subject | Surgery | - |
dc.title | What is the appropriate timing for surgery after neoadjuvant chemoradiation for esophageal cancer | en_US |
dc.type | Conference_Paper | en_US |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0364-2313&volume=35&issue=Suppl. 1&spage=S172, Abstract ID: 0450&epage=&date=2011&atitle=What+is+the+appropriate+timing+for+surgery+after+neoadjuvant+chemoradiation+for+esophageal+cancer | - |
dc.identifier.email | Tong, D: esodtong@hku.hk | en_US |
dc.identifier.email | Law, S: slaw@hku.hk | en_US |
dc.identifier.email | Kwong, DLW: dlwkwong@hkucc.hku.hk | en_US |
dc.identifier.email | Chan, SY: fsychan@hku.hk | en_US |
dc.identifier.authority | Law, S=rp00437 | en_US |
dc.identifier.authority | Kwong, DLW=rp00414 | en_US |
dc.identifier.hkuros | 196103 | en_US |
dc.identifier.hkuros | 196108 | - |
dc.identifier.volume | 35 | - |
dc.identifier.issue | suppl. 1 | - |
dc.identifier.spage | S172, abstract no. 0450 | - |
dc.identifier.epage | S172, abstract no. 0450 | - |
dc.description.other | The International Surgical Week (ISW2011), Yokohama, Japan, 28 August-1 September 2011. In World Journal of Surgery, 2011, v. 35 suppl. 1, p. S172, abstract no. 0450 | - |
dc.identifier.issnl | 0364-2313 | - |